MSD Animal Health has announced the European launch of Activyl, a novel flea and tick treatment containing indoxacarb, an active that is new to animal health and which - uniquely - is activated by flea metabolism.
Activyl is licensed to treat and prevent…
MSD Animal Health has launched the Big Flea Guarantee, a new marketing initiative to support its flea and tick treatment for dogs, Bravecto.
The launch began with a live webcast from the University of Bristol offering advice for pet owners on managing…
MSD Animal Health has announced the launch of The Big Tick Project, both to investigate whether ticks are carrying more pathogens and to raise awareness amongst the public.
The company highlights research which shows that nationally, tick distribution…
Amanda Melvin, Senior Product Manager, said: "We’re very excited about…
Matt, who contracted Lyme disease early last year, has…
The new spot on, which is complementary to the Bravecto dog chew, is the only one to provide 12 week protection for both fleas and ticks, including Rhipicephalus sang…
Bravecto Plus contains fluralaner (280 mg/ml), an ectoparasiticide which provides systemic activity against ticks (lxodes ricinus) and fleas (
Claire Gotto, Veterinary Advisor at MSD Animal Health…
The company points to a study which showed that cats treated Bravecto Plus showed no visible signs of mites at 14 days and…
MSD's push is being driven…
This new injectable fluralaner formulation is approved for the immediate and persistent killing…
Bravecto Triuno is approved for the treatment of tick…
That'll bring the GB list price down from £434 to £347.20, something which can only be good news at a time when the veterinary profession is…